36 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Efnb1tm1.1Jwu/Efnb1tm1.1Jwu Efnb2tm1.1Jwu/Efnb2tm1.1Jwu Tg(Lck-cre)I540Jxm/0 B6.Cg-Efnb2tm1.1Jwu Efnb1tm1.1Jwu Tg(Lck-cre)I540Jxm	abnormal bone marrow cell morphology/development	J:178148
	abnormal T cell differentiation	J:178148
	abnormal T-helper 1 cell differentiation	J:178148
	abnormal T-helper 17 cell differentiation	J:178148
	decreased CD4-positive, alpha-beta T cell number	J:178148
	decreased CD8-positive, alpha-beta T cell number	J:178148
	decreased DN4 thymocyte number	J:178148
	decreased double-positive T cell number	J:178148
	decreased spleen weight	J:178148
	decreased T cell number	J:178148
	decreased thymus weight	J:178148
	increased DN3 thymocyte number	J:178148
	increased double-negative T cell number	J:178148
	increased length of allograft survival	J:178148
	increased susceptibility to Riboviria infection	J:178148
	increased thymocyte apoptosis	J:178148
	small spleen	J:178148
	small thymus	J:178148
	spleen hypoplasia	J:178148
	thymus hypoplasia	J:178148
Efnb1tm1.1Sor/Efnb1+ Efnb2tm2Sor/Efnb2+ involves: 129S4/SvJaeSor * C57BL/6J	abnormal tracheal cartilage morphology	J:143845
	failure of eyelid fusion	J:143845
	small salivary gland	J:143845
Efnb1tm1.1Sor/Efnb1+ Efnb2tm2Sor/Efnb2tm2Sor involves: 129S4/SvJaeSor * C57BL/6	abnormal coronal suture morphology	J:115952
	abnormal frontal bone morphology	J:115952
Efnb1tm1.1Sor/Y Efnb2tm2Sor/Efnb2+ involves: 129S4/SvJaeSor * C57BL/6J	abnormal tracheal cartilage morphology	J:143845
	failure of eyelid fusion	J:143845
	small salivary gland	J:143845
Efnb1tm1.1Sor/Y Efnb2tm2Sor/Efnb2tm2Sor involves: 129S4/SvJaeSor * C57BL/6	normal craniofacial phenotype	J:115952
Efnb2tm1And/Efnb2+ Rbpjtm1Kyo/Rbpjtm1Kyo involves: 129S2/SvPas * 129S7/SvEvBrd	abnormal vascular development	J:93125
Efnb2tm1Henk/Efnb2+ Ephb2tm2Paw/Ephb2tm2Paw either: 129 or (involves: 129 * C57BL/6) or (involves: 129 * CD-1)	hypospadia	J:91491
Efnb2tm1Henk/Efnb2+ Ephb2tm2Paw/Ephb2tm2Paw Ephb3tm1Kln/Ephb3+ either: 129 or (involves: 129 * C57BL/6) or (involves: 129 * CD-1)	hypospadia	J:91491
Efnb2tm1Henk/Efnb2+ Ephb2tm1Paw/Ephb2+ involves: 129S1/Sv * 129X1/SvJ * CD-1	circling	J:116671
Efnb2tm1Sor/Efnb2tm1Sor 129S4/SvJaeSor-Efnb2tm1Sor	no abnormal phenotype detected	J:143845
Efnb2tm5.1Kln/Efnb2tm5.1Kln involves: C57BL/6	abnormal afferent lymphatic vessel morphology	J:95885
	abnormal lymph circulation	J:95885
	abnormal lymphatic vessel morphology	J:95885
	chylothorax	J:95885
	postnatal lethality, complete penetrance	J:95885
Efnb2tm5.1Kln/Efnb2tm5.1Kln involves: CD-1	abnormal lymphatic vessel morphology	J:95885
	chylothorax	J:95885
	premature death	J:95885
Efnb2tm5.1Kln/Efnb2tm5.1Kln Flt4tm1Ali/Flt4+ involves: C57BL/6	abnormal afferent lymphatic vessel morphology	J:95885
	abnormal lymphatic vessel morphology	J:95885
Efnb2tm6Kln/Efnb2tm6Kln involves: C57BL/6	abnormal lymph circulation	J:95885
	abnormal lymphatic vessel morphology	J:95885